A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol

Completed · Phase 1

Conditions studied: Dravet Syndrome, Lennox Gastaut Syndrome

In brief

This is an open label study to evaluate the safety of ZX008 (fenfluramine) in patients with Dravet syndrome (DS) or Lennox Gastaut syndrome (LGS) who are being administered cannabidiol (CBD).

Key facts

Study ID
NCT03467113
Run by
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
People needed
9
Starts
2018-01-19
Expected to finish
2020-06-24
Last updated by the study team
2023-12-01

Who can join

Age: 2 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.